The return of PRO 140, a CCR5-directed mAb.

Thompson, Melanie A

Thompson, Melanie A.

Affiliation

Thompson MA; AIDS Research Consortium of Atlanta, Atlanta, Georgia, USA.

Curr Opin HIV AIDS ; 13(4): 346-353, 2018 07.

Article in En | MEDLINE | ID: mdl-29708899

Subject(s)

Anti-HIV Agents/administration & dosage; Antibodies, Monoclonal, Humanized/administration & dosage; CCR5 Receptor Antagonists/administration & dosage; HIV Antibodies/administration & dosage; HIV Infections/drug therapy; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; HIV Infections/genetics; HIV Infections/metabolism; Humans; Receptors, CCR5/genetics; Receptors, CCR5/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Antibodies / HIV Infections / Anti-HIV Agents / Antibodies, Monoclonal, Humanized / CCR5 Receptor Antagonists Limits: Humans Language: En Journal: Curr Opin HIV AIDS Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google